Antibiotic Treatment for Diverticulitis
For uncomplicated diverticulitis (Hinchey 1a), antibiotics should be omitted in immunocompetent patients without systemic manifestations of infection, as they do not improve outcomes compared to symptomatic treatment alone. 1, 2
Classification and Treatment Algorithm
Uncomplicated Diverticulitis (Hinchey 1a)
Immunocompetent patients without systemic manifestations:
High-risk patients (immunocompromised, elderly, with comorbidities, or with systemic manifestations):
Complicated Diverticulitis
Small diverticular abscess:
- Antibiotic therapy alone for 7 days 1
Large diverticular abscess:
Antibiotic Selection
Outpatient Treatment
- Oral regimens:
Inpatient Treatment
- IV regimens with gram-negative and anaerobic coverage:
Patient Selection for Outpatient Treatment
Outpatient treatment is appropriate for patients who:
- Can tolerate oral intake
- Have no significant comorbidities
- Have adequate pain control with oral analgesics
- Have appropriate home support
- Have temperature <100.4°F
- Have pain score <4 on visual analog scale 2, 3, 4
Important Considerations
- Recent evidence shows oral antibiotics are equally effective as IV antibiotics for uncomplicated diverticulitis, allowing for outpatient management in appropriate patients 5, 4
- Outpatient treatment can reduce healthcare costs by approximately €1,600 per patient compared to inpatient treatment 4
- Risk factors for treatment failure include CT performed between midnight and 6 AM, Ambrosetti score of 4, and free air around the colon 6
- Immunocompromised patients require a lower threshold for imaging, antibiotic treatment, and surgical consultation 1
- Duration of therapy should be extended to 10-14 days in immunocompromised patients 1
Prevention of Recurrence
- High-fiber diet (fruits, vegetables, whole grains)
- Regular physical activity
- Maintaining normal BMI
- Smoking cessation
- Avoiding non-aspirin NSAIDs 1, 2
The evidence clearly shows that antibiotics can be safely omitted in uncomplicated diverticulitis for immunocompetent patients, while those with risk factors or complicated disease require appropriate antibiotic coverage and potentially more aggressive interventions.